These results indicate that the LSD1-GFI1 interaction is crucial for the differentiation block characteristic of AML, and both the scaffolding and enzymatic functions of LSD1 need to be targeted to retain the differentiative and anti-leukemic activity of LSD1 inhibition. Here, KDM1A is linked to acute myeloid leukemia.